Seeking Alpha

DNDN
Dendreon Corporation

5/23/2012, 7:32 AM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
DNDN Market Currents more »
DNDN Instablog posts more »
  • Dendreon: Provenge should be given as soon as possible.
    Sat, Mar 24 Giancarlo Nicoli Comment!
  • Penny Stock Alerts
    Tue, Mar 13 Jonathan Spencer Comment!
  • An Update On 10 Stocks That Could Collapse This Year
    Fri, Feb 24 Bill Maurer Comment!
  • Dendreon's Provenge Works. Little Guide To Debunking Inaccurate Info
    Wed, Feb 8 Giancarlo Nicoli 2 Comments
  • Stocks Finish Off The Lows As Volume Drops
    Tue, Feb 7 Joshua Hayes Comment!
Write a post on DNDN
DNDN StockTalks
DNDN vs. ETF Alternatives
Company Description

Dendreon Corporation (“Dendreon”, the “Company”, “we”, “us”, or “our”), is a biotechnology company focused on the discovery, development and commercialization of novel therapeutics that may significantly improve cancer treatment options for patients. Our product portfolio includes active... More

Sector: Healthcare
Industry: Biotechnology
Country: United States